| Unique ID issued by UMIN | UMIN000029199 |
|---|---|
| Receipt number | R000033377 |
| Scientific Title | Open study of ORM |
| Date of disclosure of the study information | 2017/09/20 |
| Last modified on | 2018/09/28 14:21:49 |
Open study of ORM
Open study of ORM
Open study of ORM
Open study of ORM
| Japan |
periodontal disease
| Dental medicine |
Others
NO
To confirm the efficacy and safety of ORM in periodontal disease patients
Safety,Efficacy
Measurement of periodontal disease index at week4 .Taking photography of oral cavity at week4.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
| Medicine |
administer ORM twice daily for 4weeks
| 20 | years-old | <= |
| 64 | years-old | >= |
Male and Female
-Patients aged 20 to 64 years on the day of signing the informed consent
-Mild to moderate periodontal disease patients
-Patients who have systemic diseases thought to affect evaluation of this study
-Patients who have serious oral diease thought to affect evaluation of this study
-Patients who smoke
10
| 1st name | |
| Middle name | |
| Last name | Yoshio Shimabukuro |
Shimabukuro Dental Clinic
-
1-5-6Tezukayamahigashi, Sumiyoshi, Osaka, Japan
06-6675-0418
smbk@dental.email.ne.jp
| 1st name | |
| Middle name | |
| Last name | Masahiko Kawai |
ROHTO pharmaceutical CO.,LTD
Clinical development group Development & Planning office
6-5-4Kunimidai, Kizugawa, Kyoto, Japan
0774-71-8820
kawaim@rohto.co.jp
ROHTO pharmaceutical CO.,LTD
ROHTO pharmaceutical CO.,LTD
Profit organization
NO
| 2017 | Year | 09 | Month | 20 | Day |
Published
Completed
| 2017 | Year | 09 | Month | 11 | Day |
| 2017 | Year | 09 | Month | 25 | Day |
| 2017 | Year | 09 | Month | 20 | Day |
| 2018 | Year | 09 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033377